[1]
|
NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, AND TISSUE SPECIFICITY.
TISSUE=Peripheral blood leukocyte;
PubMed=3500230 [NCBI, ExPASy, EBI, Israel, Japan]
Gondo H.,
Kudo J.,
White J.W.,
Barr C.,
Selvanayagam P.,
Saunders G.F.;
"Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes.";
J. Immunol. 139:3840-3848(1987).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
DOI=10.1007/s11010-005-7642-4; PubMed=16010977 [NCBI, ExPASy, EBI, Israel, Japan]
Yang S.P.,
Lee H.J.,
Su Y.;
"Molecular cloning and structural characterization of the functional human thymosin beta4 gene.";
Mol. Cell. Biochem. 272:97-105(2005).
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
PROTEIN SEQUENCE OF 2-44, AND INTERACTION WITH ACTIN.
PubMed=1999398 [NCBI, ExPASy, EBI, Israel, Japan]
Safer D.,
Elzinga M.,
Nachmias V.T.;
"Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable.";
J. Biol. Chem. 266:4029-4032(1991).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 8-44, AND INDUCTION.
DOI=10.1016/0092-8674(84)90270-8; PubMed=6548414 [NCBI, ExPASy, EBI, Israel, Japan]
Friedman R.L.,
Manly S.P.,
McMahon M.,
Kerr I.M.,
Stark G.R.;
"Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells.";
Cell 38:745-755(1984).
|
[6]
|
STRUCTURE BY NMR OF WILD-TYPE AND OF MUTANTS LYS-12; SER-16 AND LEU-18 IN COMPLEX WITH ACTIN.
DOI=10.1046/j.1432-1327.2000.01380.x; PubMed=10848969 [NCBI, ExPASy, EBI, Israel, Japan]
Simenel C.,
Van Troys M.,
Vandekerckhove J.,
Ampe C.,
Delepierre M.;
"Structural requirements for thymosin beta4 in its contact with actin. An NMR-analysis of thymosin beta4 mutants in solution and correlation with their biological activity.";
Eur. J. Biochem. 267:3530-3538(2000).
|
|
ExPASy Home page
CBR Canada
